Aravive, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue
Grant Revenue
Collaboration Revenue
Collaborative Arrangement
Total revenue

Operating expenses
Research and development
Write-off of acquired in-process research and development
General and administrative
Loss on impairment of long-lived assets
Total operating expenses
Loss from operations

Other income (expense), net:
Interest income
Interest expense
Change in fair value of warrant liability
Other income, net
Benefit from income taxes
Total other income (expense), net
Net loss
Net loss per share - basic and diluted (in dollars per share)
Weighted-average common shares used to compute basic and diluted net loss per share (in shares)

Comments